pe
pep-04927 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (IGNTLI)

An experimental small peptide that blocks a body enzyme which normally raises blood pressure; being studied as a possible treatment for high blood pressure, not yet an approved drug.

statuscomputed targetACE length6 aa refs3
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.520
pTM0.627
avg pLDDT86.1
ranking score0.793
STRUCTURE · PEP-04927 × ACE
ranking0.793
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
IGNTLI
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.5202890038490295 boltz-2
ranking score 0.7932440042495728 boltz-2
3-letter notation
Ile-Gly-Asn-Thr-Leu-Ile
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategycolabfold_nvidia
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-25
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (IGNTLI) (pep-04927, v1). PeptideModel. https://peptidemodel.com/card/pep-04927
@peptide{pep04927,
  sequence = {IGNTLI},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use